Jupiter Topco LLC Makes New Investment in Establishment Labs Holdings Inc. $ESTA

Jupiter Topco LLC bought a new stake in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 8,376 shares of the company’s stock, valued at approximately $719,000.

Several other hedge funds and other institutional investors have also made changes to their positions in ESTA. KBC Group NV purchased a new stake in shares of Establishment Labs during the first quarter worth approximately $28,000. Quarry LP purchased a new position in Establishment Labs in the 3rd quarter valued at $34,000. Northwestern Mutual Wealth Management Co. acquired a new stake in Establishment Labs during the 2nd quarter worth $43,000. Kestra Advisory Services LLC acquired a new stake in Establishment Labs during the 4th quarter worth $47,000. Finally, Osaic Holdings Inc. grew its holdings in shares of Establishment Labs by 900.0% during the second quarter. Osaic Holdings Inc. now owns 2,000 shares of the company’s stock worth $85,000 after buying an additional 1,800 shares in the last quarter. Hedge funds and other institutional investors own 72.91% of the company’s stock.

Wall Street Analyst Weigh In

ESTA has been the subject of a number of recent research reports. Weiss Ratings reiterated a “sell (e+)” rating on shares of Establishment Labs in a research report on Wednesday, June 24th. Citigroup raised shares of Establishment Labs from a “neutral” rating to a “buy” rating and set a $92.00 price objective for the company in a research note on Thursday, August 13th. Mizuho increased their price objective on shares of Establishment Labs from $100.00 to $105.00 and gave the company an “outperform” rating in a report on Wednesday, July 15th. TD Cowen raised their target price on shares of Establishment Labs from $95.00 to $117.00 and gave the stock a “buy” rating in a research note on Monday, August 3rd. Finally, BTIG Research restated a “buy” rating and set a $103.00 target price on shares of Establishment Labs in a report on Tuesday, September 1st. Eight equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Establishment Labs presently has a consensus rating of “Moderate Buy” and an average price target of $100.25.

Establishment Labs Price Performance

Shares of ESTA stock opened at $74.29 on Monday. The company has a debt-to-equity ratio of 12.11, a current ratio of 3.84 and a quick ratio of 2.52. The company has a market capitalization of $2.21 billion, a PE ratio of -56.71 and a beta of 1.05. The firm’s 50-day moving average is $83.45 and its two-hundred day moving average is $74.89. Establishment Labs Holdings Inc. has a 12 month low of $36.53 and a 12 month high of $97.59.

Establishment Labs (NASDAQ:ESTA) last announced its quarterly earnings results on Thursday, August 6th. The company reported ($0.39) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.34) by ($0.05). Establishment Labs had a negative return on equity of 196.69% and a negative net margin of 15.82%.The firm had revenue of $67.54 million for the quarter, compared to analyst estimates of $65.79 million. During the same quarter in the prior year, the business earned ($0.57) EPS. The firm’s quarterly revenue was up 31.7% on a year-over-year basis. Analysts predict that Establishment Labs Holdings Inc. will post -1.15 earnings per share for the current year.

Establishment Labs Profile

Establishment Labs Holdings Inc is a global medical technology company specializing in the design, development and manufacture of silicone gel breast implants for aesthetic and reconstructive surgery. The company’s proprietary portfolio is built around patient-focused safety, customization and innovation, offering solutions intended to enhance surgical outcomes and support clinical traceability.

The company’s flagship products fall under the Motiva® brand, which includes a range of ergonomic and round breast implants featuring SilkSurface® texturing and an embedded Q Inside® Safety microtransponder for unique implant identification.